第一选择
帕利夫明
:
在接受化疗之前3天和之后3天以60μg/kg的剂量每日静脉注射一次,连续治疗3天。
对于正在接受骨髓毒性治疗、需要造血支持的血液系统恶性肿瘤患者,重组人角质细胞生长因子- 1(帕利夫明)可减少严重口腔黏膜炎的发生率和持续时间。[11]Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351:2590-2598.http://www.nejm.org/doi/full/10.1056/NEJMoa040125#t=articlehttp://www.ncbi.nlm.nih.gov/pubmed/15602019?tool=bestpractice.com
在接受化疗前3天和化疗后3天连续给药。[25]Saunders DP, Epstein JB, Elad S, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21:3191-3207.http://www.ncbi.nlm.nih.gov/pubmed/23832272?tool=bestpractice.com[29]Spielberger R, Emmanouilides C, Stiff P, et al. Use of recombinant human keratinocyte growth factor (rHuKGF) can reduce severe oral mucositis in patients (pts) with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation (auto-PBPCT) after radiation-based conditioning - results of a phase 3 trial. Proc Am Soc Clin Oncol. 2003;22:abstr 3642.
对于接受自体干细胞移植,进行高剂量化疗和全身放疗的血液系统恶性肿瘤患者,建议使用帕利夫明。[27]Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21:343-355.http://www.ncbi.nlm.nih.gov/pubmed/2298709?tool=bestpractice.com接受同种异体移植的患者可以考虑使用这种药物。[16]Hensley ML, Hagerty KL, Kewalramani T, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol. 2009;27:127-145.http://jco.ascopubs.org/cgi/content/full/27/1/127http://www.ncbi.nlm.nih.gov/pubmed/19018081?tool=bestpractice.com对于在未使用全身放疗、非干细胞移植的情况下或者实体瘤治疗时的用药,目前尚无充足的数据。[16]Hensley ML, Hagerty KL, Kewalramani T, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol. 2009;27:127-145.http://jco.ascopubs.org/cgi/content/full/27/1/127http://www.ncbi.nlm.nih.gov/pubmed/19018081?tool=bestpractice.com